Comparable stake leader
Ayrton Capital LLC
SEC ownership of Ocean Biomedical, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001869974.
Disclosed value leader
Ayrton Capital LLC
Comparable rows
1/11
Latest evidence
31 Dec 2024
- Public ticker
- OCEA on OTC
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Ayrton Capital LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 11
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Ayrton Capital LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Dec 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001869974
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Ocean Biomedical, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Ayrton Capital LLC
Comparable rows
1/11
Latest evidence
31 Dec 2024
13D/G
3/4/5
Lead comparable stake: 9.9%
10 rows are not safely comparable across share classes.
13D/G row: Ayrton Capital LLC
Showing 1-8 of 11 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 9.9%.
1 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 1
Ayrton Capital LLC
9.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
9.9%
|
$77,473
3,873,632 shares
|
$0 | 31 Dec 2024 |
| Chirinjeev Kathuria |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
22,799,608 shares
|
— | 02 Oct 2023 |
| Aesther Healthcare Sponsor, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
2,625,000 shares
|
— | 03 Nov 2021 |
| Surendra K. Ajjarapu |
3/4/5
Director
|
—
mixed-class rows
|
—
3,082,252 shares
mixed-class rows
|
— | 22 Mar 2023 |
| Michael L. Peterson |
3/4/5
Director
|
—
mixed-class rows
|
—
355,000 shares
mixed-class rows
|
— | 28 Feb 2023 |
| Jack A. Elias |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
| Jerome Ringo |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
| Jonathan D. Kurtis |
3/4/5
Director
|
—
class O/S missing
|
—
75,000 shares
|
— | 15 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Ocean Biomedical, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Aesther Healthcare Sponsor, LLC
Net 12M change
$0
Latest report
02 Oct 2023
Recent insider transactions for Ocean Biomedical, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.